Works matching IS 1341-9625 AND VI 17 AND IP 3 AND DT 2012


Results: 18
    1
    2
    3
    4
    5

    F-Fluorodeoxyglucose positron emission tomography optimizes neoadjuvant chemotherapy for primary breast cancer to achieve pathological complete response.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 276, doi. 10.1007/s10147-011-0287-2
    By:
    • Ueda, Shigeto;
    • Saeki, Toshiaki;
    • Shigekawa, Takashi;
    • Omata, Jiro;
    • Moriya, Tomoyuki;
    • Yamamoto, Junji;
    • Osaki, Akihiko;
    • Fujiuchi, Nobuko;
    • Misumi, Misono;
    • Takeuchi, Hideki;
    • Sakurai, Takaki;
    • Tsuda, Hitoshi;
    • Tamura, Katsumi;
    • Ishida, Jiro;
    • Abe, Yoshiyuki;
    • Imabayashi, Etsuko;
    • Kuji, Ichiei;
    • Matsuda, Hiroshi
    Publication type:
    Article
    6
    7
    8
    9
    10

    Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort study.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 233, doi. 10.1007/s10147-011-0280-9
    By:
    • Matsumoto, Koji;
    • Hirai, Yasuo;
    • Furuta, Reiko;
    • Takatsuka, Naoyoshi;
    • Oki, Akinori;
    • Yasugi, Toshiharu;
    • Maeda, Hiroo;
    • Mitsuhashi, Akira;
    • Fujii, Takuma;
    • Kawana, Kei;
    • Iwasaka, Tsuyoshi;
    • Yaegashi, Nobuo;
    • Watanabe, Yoh;
    • Nagai, Yutaka;
    • Kitagawa, Tomoyuki;
    • Yoshikawa, Hiroyuki
    Publication type:
    Article
    11
    12
    13
    14

    Predicting the effects of chemoradiotherapy for squamous cell carcinoma of the esophagus by induction chemotherapy response assessed by positron emission tomography: toward PET-response-guided selection of chemoradiotherapy or esophagectomy.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 225, doi. 10.1007/s10147-011-0278-3
    By:
    • Ishihara, Ryu;
    • Yamamoto, Sachiko;
    • Iishi, Hiroyasu;
    • Nagai, Kengo;
    • Matui, Fumi;
    • Kawada, Natsuko;
    • Ohta, Takashi;
    • Kanzaki, Hiromitsu;
    • Hanafusa, Masao;
    • Hanaoka, Noboru;
    • Takeuchi, Yoji;
    • Higashino, Koji;
    • Uedo, Noriya;
    • Sugimoto, Naotoshi;
    • Kawaguchi, Yoshifumi;
    • Nishiyama, Kinji;
    • Motoori, Masaaki;
    • Yano, Masahiko;
    • Hosoki, Takuya
    Publication type:
    Article
    15
    16
    17
    18

    Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 3, p. 204, doi. 10.1007/s10147-011-0275-6
    By:
    • Narita, Shintaro;
    • Tsuchiya, Norihiko;
    • Yuasa, Takeshi;
    • Maita, Shinya;
    • Obara, Takashi;
    • Numakura, Kazuyuki;
    • Tsuruta, Hiroshi;
    • Saito, Mitsuru;
    • Inoue, Takamitsu;
    • Horikawa, Yohei;
    • Satoh, Shigeru;
    • Habuchi, Tomonori
    Publication type:
    Article